DHEA Before IVF for Low Ovarian Reserve in Shillong: What to Ask First

Some small studies have investigated androgen supplementation before ovarian stimulation, but uncertainty remains about which patients, if any, benefit and whether live-birth outcomes improve. The HFEA lists androgen supplementation among fertility add-ons with insufficient evidence for a firm benefit rating. Research methods, selection of patients and treatment regimens differ, so a personal dose or course length cannot be inferred from an isolated trial or online success story.

Androgen exposure can produce acne, unwanted hair changes or other effects and may be unsuitable in certain medical conditions. The clinician should review symptoms of androgen excess, medication interactions, fertility history and any suspicion of pregnancy. “Natural supplement” is a marketing category, not a guarantee of safety or regulatory oversight; product purity and the actual ingredient may be uncertain.

A useful review is selective, not a demand to repeat every fertility test. Bring the following material to the clinician who is actually responsible for the plan:

1. AMH, AFC and age with reference dates and prior ovarian stimulation response.

2. Any DHEA product label, dose and online or clinician recommendation.

3. History of androgen excess, PCOS, liver conditions and medications.

4. Clear written plan specifying why supplementation is being considered.

These documents help the team check whether a result was obtained at the right time, with the right method, for the right question. If another person or laboratory provided a report, record their advice without assuming that the two teams have spoken directly. People often receive a laboratory label without being told what action it demands. The label alone rarely supplies age, prior treatment response, timing, test method and relevant history. Two specialists may reasonably want different additional information. Request a short rationale that separates what is known from what remains a hypothesis and what can safely be decided later.

A safe consultation asks whether diminished ovarian reserve is based on age, AMH, AFC and actual stimulation response, and whether a hormone-based pretreatment has a clear evidence-backed indication. The provider should explain standard options and what outcome they expect DHEA to change. If benefit is uncertain, declining it should not block access to ordinary IVF care.

| Possible path | What to confirm before choosing it |

|---|---|

| Proceed without DHEA | Use evidence-based stimulation planning when benefit remains unproven. |

| Review a proposed course | Discuss indication, safety, interaction risks and monitoring with a doctor. |

| Address a different endocrine issue | Investigate a true hormonal disorder rather than masking it with a supplement. |

This is a discussion framework, not an algorithm or a prescription. A clinician may recommend a different sequence because of age, symptoms, medical history or the timing of a treatment cycle. Keep a dated, written record of the agreed plan.

A patient in Laitumkhrah sees a video urging everyone with low AMH to take DHEA before consulting a doctor. They bring the bottle and online recommendation to a fertility appointment. Their clinician reviews ovarian reserve measures, previous cycles and androgen-related symptoms, and decides whether any supplement is appropriate rather than endorsing a generic online regimen.

The point of this example is not to predict an outcome; it shows which missing detail would make the consultation more useful. Patients in Laitumkhrah, Shillong can make consultations more productive by preparing one combined timeline of symptoms, test dates, medicines, procedures and messages from previous doctors. Keep numerical reports with reference ranges and note any laboratory change. Discuss in advance which tasks can be coordinated remotely, which must be done at an appropriate facility and who can be reached if timing shifts.

A remote consultation is useful for organising a complex case, not for making an unsupported diagnosis from a photograph of one result. A clear written plan should identify the responsible fertility clinician, the facility providing required procedures, the latest safe time for any necessary assessment and the telephone route for time-sensitive questions. Availability of specific home services in this city or locality is not verified in this article.

When discussing DHEA or androgen supplementation before IVF, start with an appropriate doctor-led consultation and a decision on the next required clinical assessment. If selected home blood collection, medication or injection support, or coordinated follow-up would help, ask HomeIVF to confirm eligibility and actual local availability first. No local clinic, partner, visiting doctor, pickup route, or service promise is implied.

A workable plan names the decision point rather than simply ordering “repeat all tests”. Ask what result would trigger further evaluation, change timing, postpone a procedure or leave the original plan unchanged. Confirm who is responsible for communicating that decision, especially if a result will arrive after working hours or you are travelling.

In this case, ask explicitly: which patient subgroup evidence fits this case; possible androgen-related adverse effects; whether the plan changes if the supplement is declined. These questions make the visit actionable and can expose unnecessary repeat tests, confusion about ownership of a time-sensitive result or a promised benefit unsupported by evidence.

Do not self-prescribe DHEA during pregnancy, while taking other hormonal medicines or with an unexplained endocrine disorder. New pronounced androgenic effects or serious symptoms merit clinical review. A supplement should not replace time-sensitive assessment when fertility evaluation is indicated.

If an active cycle is under way, new severe symptoms or an unexpected medicine or laboratory issue must be escalated to the responsible clinic rather than waiting for an article or routine follow-up. Do not self-adjust a trigger, antibiotic, progesterone or other prescription. When urgent help is necessary, use an appropriate emergency service or facility.

The useful question is not whether DHEA is popular, but whether a particular person has a clear, evidence-supported reason to use it. Ask about live-birth data, adverse effects, alternatives and monitoring.

The best next step is the one tied to your own test results and history, not the one that sounds most advanced. Seek medical advice from your treating doctor before changing care. The local service details and any additional clinical claims named in the verification section below must be checked before this page goes live.